How long should a CJC-1295 cycle be?

Published human trials do not establish a cycle length for CJC-1295. Its own human data show a single subcutaneous dose kept trough growth hormone elevated roughly 7.5-fold a week later with pulse frequency and amplitude unchanged, which is evidence against rapid tolerance at that timescale, not evidence for any particular number of weeks. Community protocols are unverified. This site does not invent a schedule. Full citations at /cycling.

Full cycling page: what is measured versus assumed

Educational use only. This database summarizes published research and is not medical advice. Where a dose appears it is a record of what a trial or clinic ran, or what people describe doing, with its source attached. Nothing here is a recommendation for personal use.

Part of cycling and clearance. Whether peptides need a break, what a half-life actually tells you, and where a real cycling mechanism has been measured. Full detail at /cycling.